Endocarditis Tied to Drug Use on the Rise, Spiked During COVID

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Centre. A new study provides more evidence that endocarditis associated with drug use is a significant and growing health concern, and further demonstrates that this risk has been exacerbated by the COVID-19 pandemic. The rate of infective endocarditis among individuals in the … Read more

Heart Failure Drug a New Treatment Option for Alcoholism?

Spironolactone, a potassium-sparing diuretic typically used to treat heart failure and hypertension, shows promise in treating alcohol use disorder (AUD), new research suggests. Researchers at the National Institute on Drug Abuse (NIDA), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), and Yale University School of Medicine investigated the impact of spironolactone on AUD. Initially, … Read more

Disparities Shrink With Aggressive Depression Screening

An analysis at a large academic health system suggests that universal screening might help to reduce problematic disparities in depression treatment. The study began soon after the US Preventive Services Task Force recommended depression screening for all adults in 2016. The task force based this recommendation on evidence that people who are screened and treated … Read more

When Sharing Sensitive Info, Patients Prefer App vs Staff: Study

Patients using a tablet-based app were more than twice as likely to disclose depression, intimate partner violence, and fall risk compared with verbal screenings, according to a new study. The study, published online today in JAMA Network Openincludes the use of mPath, a tablet-based app created by a team of researchers at Wake Forest School … Read more